Balancing CIK Cell Cancer Immunotherapy and PPAR Ligands: One Potential Therapeutic Application for CNS Malignancies
We provide evidence that PPAR ligands in combination with CIK cell immunotherapy could be a valuable option for malignant CNS tumors.
Authors
- Jingjing Pu (ORCID: https://orcid.org/0000-0002-9854-5329)
- Amit Sharma (ORCID: https://orcid.org/0000-0002-2216-5389)
- Kira Vordermark (ORCID: https://orcid.org/0009-0006-9042-6698)
- Ingo G. H. Schmidt-Wolf (ORCID: https://orcid.org/0000-0002-5655-0867)
- Jarek Maciacyzk
Institutions
- University Hospital Bonn (DE)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/cam4.70497
- Citations
- 2
- Primary Topic
- Immune Cell Function and Interaction
- Type
- article
- Field-Weighted Citation Impact
- 0.48
Funders
- Deutsche Krebshilfe